Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Statin use for cardiovascular disease prevention: perceptions among people living with HIV in the United States.

  • Authors : Ogunbajo A; RAND Corporation, Arlington, VA, United States of America. .; Todd I

Subjects: Hydroxymethylglutaryl-CoA Reductase Inhibitors*/Hydroxymethylglutaryl-CoA Reductase Inhibitors*/Hydroxymethylglutaryl-CoA Reductase Inhibitors*/therapeutic use ; Cardiovascular Diseases* ; HIV Infections*

  • Source: BMC primary care [BMC Prim Care] 2024 Apr 17; Vol. 25 (1), pp. 116. Date of Electronic Publication: 2024 Apr 17.Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 9918300889006676 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Omega-3 ( n -3) Fatty Acid-Statin Interaction: Evidence for a Novel Therapeutic Strategy for Atherosclerotic Cardiovascular Disease.

  • Authors : Djuricic I; Department of Bromatology, Faculty of Pharmacy, University of Belgrade, 11221 Belgrade, Serbia.; Calder PC

Subjects: Fatty Acids, Omega-3*/Fatty Acids, Omega-3*/Fatty Acids, Omega-3*/pharmacology ; Fatty Acids, Omega-3*/Fatty Acids, Omega-3*/Fatty Acids, Omega-3*/therapeutic use ; Hydroxymethylglutaryl-CoA Reductase Inhibitors*/Hydroxymethylglutaryl-CoA Reductase Inhibitors*/Hydroxymethylglutaryl-CoA Reductase Inhibitors*/therapeutic use

  • Source: Nutrients [Nutrients] 2024 Mar 27; Vol. 16 (7). Date of Electronic Publication: 2024 Mar 27.Publisher: MDPI Publishing Country of Publication: Switzerland NLM ID: 101521595 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Is there a shift from cardiovascular to cancer death in lipid-lowering trials? A systematic review and meta-analysis.

  • Authors : Bolt L; Institute of Primary Health Care (BIHAM), University of Bern, Bern, Switzerland.; Department of General Internal Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.

Subjects: Cardiovascular Diseases* ; Hydroxymethylglutaryl-CoA Reductase Inhibitors* ; Neoplasms*/Neoplasms*/Neoplasms*/drug therapy

  • Source: PloS one [PLoS One] 2024 Feb 08; Vol. 19 (2), pp. e0297852. Date of Electronic Publication: 2024 Feb 08 (Print Publication: 2024).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

Record details

×
Academic Journal

A Systematic Review of Statins for the Treatment of Nonalcoholic Steatohepatitis: Safety, Efficacy, and Mechanism of Action.

  • Authors : Zhang S; School of Pharmacy, Guangdong Pharmaceutical University, Guangzhou 510006, China.; Ren X

Subjects: Non-alcoholic Fatty Liver Disease*/Non-alcoholic Fatty Liver Disease*/Non-alcoholic Fatty Liver Disease*/drug therapy ; Non-alcoholic Fatty Liver Disease*/Non-alcoholic Fatty Liver Disease*/Non-alcoholic Fatty Liver Disease*/metabolism ; Hydroxymethylglutaryl-CoA Reductase Inhibitors*/Hydroxymethylglutaryl-CoA Reductase Inhibitors*/Hydroxymethylglutaryl-CoA Reductase Inhibitors*/therapeutic use

  • Source: Molecules (Basel, Switzerland) [Molecules] 2024 Apr 19; Vol. 29 (8). Date of Electronic Publication: 2024 Apr 19.Publisher: MDPI Country of Publication: Switzerland NLM ID: 100964009 Publication Model: Electronic Cited Medium: Internet ISSN: 1420-3049

Record details

×
Academic Journal

Impact of statin treatment on cardiovascular risk in patients with type 1 diabetes: a population-based cohort study.

  • Authors : Yoo J; Department of Neurology, Yongin Severance Hospital, Yonsei University College of Medicine, 363 Dongbaekjukjeon-daero, Giheung-gu, Yongin-si, Gyeonggi-do, 16995, Republic of Korea.; Jeon J

Subjects: Hydroxymethylglutaryl-CoA Reductase Inhibitors*/Hydroxymethylglutaryl-CoA Reductase Inhibitors*/Hydroxymethylglutaryl-CoA Reductase Inhibitors*/therapeutic use ; Diabetes Mellitus, Type 1*/Diabetes Mellitus, Type 1*/Diabetes Mellitus, Type 1*/complications ; Diabetes Mellitus, Type 1*/Diabetes Mellitus, Type 1*/Diabetes Mellitus, Type 1*/drug therapy

  • Source: Journal of translational medicine [J Transl Med] 2023 Nov 12; Vol. 21 (1), pp. 806. Date of Electronic Publication: 2023 Nov 12.Publisher: BioMed Central Country of Publication: England NLM ID: 101190741 Publication Model: Electronic Cited Medium: Internet ISSN: 1479-5876

Record details

×
Academic Journal

Comparison of on-Statin Lipid and Lipoprotein Levels for the Prediction of First Cardiovascular Event in Type 2 Diabetes Mellitus.

  • Authors : Kim JY; Division of Endocrinology and Metabolism, Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea.; Choi J

Subjects: Hydroxymethylglutaryl-CoA Reductase Inhibitors*/Hydroxymethylglutaryl-CoA Reductase Inhibitors*/Hydroxymethylglutaryl-CoA Reductase Inhibitors*/therapeutic use ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/complications ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy

  • Source: Diabetes & metabolism journal [Diabetes Metab J] 2023 Nov; Vol. 47 (6), pp. 837-845. Date of Electronic Publication: 2023 Aug 23.Publisher: Korean Diabetes Association Country of Publication: Korea (South) NLM ID: 101556588 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Proprotein convertase subtilisn/kexin type 9 inhibitors and small interfering RNA therapy for cardiovascular risk reduction: A systematic review and meta-analysis.

  • Authors : Imran TF; Providence VA Medical Center, Providence, Rhode Island, United States of America.; Lifespan Cardiovascular Institute, Rhode Island and Miriam Hospitals, Providence, Rhode Island, United States of America.

Subjects: Myocardial Infarction*/Myocardial Infarction*/Myocardial Infarction*/drug therapy ; Atherosclerosis*/Atherosclerosis*/Atherosclerosis*/drug therapy ; Anticholesteremic Agents*/Anticholesteremic Agents*/Anticholesteremic Agents*/therapeutic use

  • Source: PloS one [PLoS One] 2023 Dec 06; Vol. 18 (12), pp. e0295359. Date of Electronic Publication: 2023 Dec 06 (Print Publication: 2023).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

Record details

×
Academic Journal

Identification of subgroups within a Japanese older adult population for whom statin therapy is effective in reducing mortality.

  • Authors : Funaki D; Graduate School of Public Health, Shizuoka Graduate University of Public Health, Shizuoka, Japan.; Kaneda H

Subjects: Atherosclerosis*/Atherosclerosis*/Atherosclerosis*/prevention & control ; Cardiovascular Diseases*/Cardiovascular Diseases*/Cardiovascular Diseases*/prevention & control ; Hydroxymethylglutaryl-CoA Reductase Inhibitors*/Hydroxymethylglutaryl-CoA Reductase Inhibitors*/Hydroxymethylglutaryl-CoA Reductase Inhibitors*/therapeutic use

  • Source: PloS one [PLoS One] 2023 Dec 01; Vol. 18 (12), pp. e0295052. Date of Electronic Publication: 2023 Dec 01 (Print Publication: 2023).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

Record details

×
Academic Journal

Beyond the Cardiovascular Effects of Glucagon-like Peptide-1 Receptor Agonists: Body Slimming and Plaque Stabilization. Are New Statins Born?

  • Authors : Lecis D; Division of Cardiology, Department of Systems Medicine, Tor Vergata University, 00133 Rome, Italy.; Prandi FR

Subjects: Hydroxymethylglutaryl-CoA Reductase Inhibitors*/Hydroxymethylglutaryl-CoA Reductase Inhibitors*/Hydroxymethylglutaryl-CoA Reductase Inhibitors*/therapeutic use ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/metabolism

  • Source: Biomolecules [Biomolecules] 2023 Nov 23; Vol. 13 (12). Date of Electronic Publication: 2023 Nov 23.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101596414 Publication Model: Electronic Cited Medium: Internet ISSN: 2218-273X

Record details

×
  • 1-10 of  4,540 results for ""Cardiovascular Diseases""